Skip to content
  • Sunday, 26 July 2026
  • 4:32 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Overcoming Cellular Differentiation Blocks
Stem Cell & Regenerative Medicine

Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Overcoming Cellular Differentiation Blocks

Dwi Wanna Jul 11, 2026 0

In a landmark advancement for hematologic oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy targeting acute…

Read More
Advanced Materials Science

RIKEN Physicists Pioneer Robust Nonreciprocal Quantum Synchronization for Phonons Overcoming Environmental Noise and Manufacturing Imperfections

Nila Kartika Wati Jul 7, 2026 0

A research team led by theoretical physicists at the RIKEN Center for Quantum Computing (RQC) has unveiled a groundbreaking theoretical…

Read More
Stem Cell & Regenerative Medicine

Novel Combination Therapy Offers Breakthrough Strategy for Overcoming Differentiation Blockade in Acute Myelogenous Leukemia

Dwi Wanna May 25, 2026 0

Acute Myelogenous Leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by its rapid progression and…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Unveils Dual-Inhibitor Strategy to Combat Acute Myelogenous Leukemia by Overcoming Cellular Differentiation Blockade

Dwi Wanna Mar 27, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…

Read More
Uranus has weird rings. Astronomers now know the source of two of themTWiV 1288: Clinical Update with Dr. Daniel Griffin Discusses Alarming Shifts in Childhood Immunization Schedules and Ongoing Public Health ConcernsBone Marrow Microenvironment Remodeling Identified as Primary Driver in the Progression of Clonal Hematopoiesis and Myelodysplastic SyndromesResearchers at the University of Nebraska–Lincoln Develop Promising New Vaccine Against Bird Flu
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ